C2orf91, located on human chromosome 2, has been implicated in ALK-positive NSCLC, showing sensitivity to alectinib in ALK-C2orf91(intergenic) (Yan et al., 2023). The gene discussed is ALK; the disease is non-small cell lung carcinoma.